Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

BioHarvest (CSE:BHSC) introduces 1st cannabis breakthrough with major medical & commercial implications

Jonathon Brown Jonathon Brown, The Market Online
0 Comments| October 25, 2022

{{labelSign}}  Favorites
{{errorMessage}}

BioHarvest (CSE:BHSC) revealed an analysis of the composition of one of its Bio CELLicitation-based cannabis products that were grown from a CBD hemp plant.


{{labelSign}}  Favorites
{{errorMessage}}


Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today

Featured Company